The FDA could soon approve the first chimeric antigen receptor (CAR) T therapies for blood cancers, but this young field is still working on how to address solid tumours, safety concerns and manufacturing issues.

中文翻译：

---

CAR T治疗进入新领域

FDA可能很快会批准首个用于血液癌的嵌合抗原受体（CAR）T治疗方法，但是这个年轻领域仍在研究如何解决实体瘤，安全性问题和制造问题。